🔗 Share this article

Chancellor Reeves has revealed she is planning "specific action to tackle cost of living pressures" in the forthcoming Budget.

During an interview with media outlets, she emphasized that curbing price rises is a shared task of both the administration and the Bank of England.

The United Kingdom's price growth is expected to be the most elevated among the G7 developed nations this calendar year and next.

Possible Energy Cost Interventions

It is understood the government could take action to lower energy bills, for example by cutting the present 5% level of VAT charged on energy supplies.

A further approach is to lower some of the policy costs currently added to bills.

Fiscal Constraints and Expert Predictions

The administration will obtain the latest draft from the official forecaster, the OBR, on the start of the week, which will reveal how much scope there is for such actions.

The consensus from most economists is that the Chancellor will have to declare tax increases or spending cuts in order to adhere to her declared borrowing rules.

Previously on Thursday, analysis indicated there was a £22bn gap for the Treasury chief to resolve, which is at the lower end of projections.

"There's a shared responsibility between the central bank and the administration to further reduce some of the causes of inflation," Reeves informed the BBC in the US capital, at the yearly gatherings of the IMF and global financial institution.

Revenue Pledges and International Issues

While a great deal of the focus has been on probable tax increases, the chancellor said the latest figures from the OBR had not altered her vow to campaign commitments not to raise tax levels on income tax, sales tax or National Insurance.

She attributed an "unpredictable world" with growing geopolitical and commercial issues for the Budget revenue measures, probably to be directed on those "most able to pay."

Global Trade Disputes

Commenting on concerns about the UK's trade ties with the Asian nation she said: "Our security interests invariably come first."

Last week's announcement by Chinese authorities to increase export controls on rare earths and other resources that are crucial for high-technology production led American leader the US President to threaten an further 100% import tax on imports from China, increasing the prospect of an full-scale trade war between the two economic giants.

The American finance chief described China's action "commercial pressure" and "a global supply chain power grab."

Questioned on accepting the US offer to join its dispute with China, the Chancellor said she was "very concerned" by China's measures and urged the Beijing authorities "not to put up barriers and restrict access."

She said the action was "harmful for the international commerce and generates additional obstacles."

"In my view there are sectors where we need to confront China, but there are also important chances to trade with China's economy, including financial services and other sectors of the economic system. We've got to get that equilibrium appropriate."

The Treasury chief also confirmed she was collaborating with international partners "regarding our own essential resources approach, so that we are more independent."

Health Service Drug Pricing and Funding

The Chancellor also acknowledged that the cost the NHS spends on drugs could increase as a consequence of current negotiations with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and funding.

Some of the world's largest pharmaceutical manufacturers have said recently that they are either pausing or abandoning projects in the United Kingdom, with several attributing the low prices they are obtaining.

Last month, the government science advisor said the cost the health service spends on medicines would have to rise to prevent businesses and drug research funding leaving the UK.

The Chancellor informed the BBC: "It has been observed due to the payment system, that medical research, innovative medicines have not been offered in the United Kingdom in the extent that they are in other European countries."

"The objective is to make sure that patients receiving care from the NHS are can access the top essential medicines in the globe. And so we are reviewing all of that, and... looking to attract increased capital into Britain."